Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Sleep Medicine

Management of Persistent Pediatric OSA After Adenotonsillectomy

Wednesday, October 4, 2023
8:00 AM - 8:50 AM East Coast USA Time
Location: Ballroom A1

    Lead Presenter(s)

  • Derek J. Lam, MD, MPH

    Associate Professor
    Oregon Health & Science University
    Portland, OR, United States

    • Mentor(s)

  • Stacey L. Ishman, MD, MPH, FACS, FAAP, HCQM

    Adjunct Clinical Professor - Otolaryngology Head & Neck Surgery - University of Cincinnati
    Instructor, University of Wisconsin - Madison
    Cincinnati, OH, United States

    • Co-Presenter(s)

  • EK

    Erin M. Kirkham, MD, MPH

    Assistant Professor - Otolaryngology Head & Neck Surgery
    University of Michigan
    ANN ARBOR, MI, United States

Disclosure(s):
Stacey L. Ishman, MD, MPH, HCQM: No relevant relationships to disclose.
Erin M. Kirkham, MD, MPH: No relevant relationships to disclose.
PROGRAM DESCRIPTION: The first line treatment for obstructive sleep apnea (OSA) in children is adenotonsillectomy (AT). Persistent OSA occurs in 30% of otherwise healthy children after AT. In children who are obese, or have craniofacial, genetic or neuromuscular disorders, persistent OSA after AT is as high as 70%. Thus, otolaryngologists are increasingly managing this challenging patient population. Despite this, there are no guidelines regarding the optimal management of children with persistent OSA after AT. The role of observation, drug induced sleep endoscopy (DISE), cine MRI, allergy evaluation, CPAP, and turbinate, palatal and tongue base surgeries will be discussed.

OUTCOME OBJECTIVE 1: • Examine the challenges and solutions for managing children with persistent OSA after AT.

OUTCOME OBJECTIVE 2: • Assess the modalities for evaluation and treatment of children with persistent OSA

OUTCOME OBJECTIVE 3: • Propose an algorithm for the management of children with persistent
OSA using case-based learning

BACKGROUND STATEMENT: Management of persistent pediatric OSA after AT is challenging with no published guidelines. There is need for a review of the latest strategies, techniques, and evidence on this topic.